Literature DB >> 21917233

[Good response of scleromyxedema and dermato-neuro syndrome to treatment with intravenous immunoglobulins].

I Bielsa1, F Benvenutti, R M Guinovart, C Ferrándiz.   

Abstract

Scleromyxedema is a potentially serious disease that can have various systemic complications. One of the most frequent forms of central nervous system involvement is dermato-neuro syndrome. High-dose intravenous immunoglobulins are among the drug treatments that have been used for this syndrome. We describe 2 patients with scleromyxedema, one of whom developed dermato-neuro syndrome. Both patients responded well to treatment with high-dose intravenous immunoglobulins. We suggest this therapy as a suitable first-line treatment for scleromyxedema and for its neurological complications.
Copyright © 2011 Elsevier España, S.L. and AEDV. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21917233     DOI: 10.1016/j.ad.2011.04.015

Source DB:  PubMed          Journal:  Actas Dermosifiliogr        ISSN: 0001-7310


  2 in total

1.  Scleromyxedema, a therapeutic dilemma.

Authors:  Julio Cesar Salas-Alanis; Brayant Martinez-Jaramillo; Minerva Gomez-Flores; Jorge Ocampo-Candiani
Journal:  Indian J Dermatol       Date:  2015 Mar-Apr       Impact factor: 1.494

2.  Early onset of scleromyxedema Arndt-Gottron associated with a monoclonal gammapathy: Successful treatment with intravenous immunoglobulins.

Authors:  Asma Kefi; Fatima Jaziri; Khaoula Ben Abdelghani; Sami Turki
Journal:  Clin Case Rep       Date:  2022-08-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.